An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
Hidradenitis suppurativa is a chronic, inflammatory disease characterized by painful nodules, abscesses, and sinuses in the intertriginous areas, with significant associated comorbidities. The pathogenesis remains unclear, although advances have been made in understanding the disease process. Management of the disease is challenging, with a wide range of treatment options available with variable clinical response. Areas covered: This review discusses the most updated studies on the complex pathogenic mechanisms of hidradenitis suppurativa and the relevant literature on the current treatment options for this condition. Expert commentary: There is increasing evidence supporting the role of Th17 cells and enhanced expression of IL-17 and IL-1β, which represent potential targets for therapy. Bacteria and biofilms are likely contributory but secondary drivers of inflammation. There is also evolving evidence to suggest the presence of systemic comorbidities associated with HS, which underlie the importance of better understanding the pathogenesis and treatment of this disease.
['Negus|Deborah|D|', 'Ahn|Christine|C|', 'Huang|William|W|']
D018407:Bacterial Physiological Phenomena D018441:Biofilms D017497:Hidradenitis Suppurativa D006801:Humans D020381:Interleukin-17 D053583:Interleukin-1beta D058504:Th17 Cells
Hidradenitis suppurativa Th17 IL-17 PAPA PASH PSTPIP1 acne inversa